Page last updated: 2024-08-24

5-bromo-4-chloro-3-indolyl beta-galactoside and ganciclovir

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with ganciclovir in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couderc, BC; Darbon, JM; de Neuville, S; Douin-Echinard, V; Malecaze, F; Manenti, S; Serres, B1
Castro, MG; Darling, JL; Lowenstein, PR; Maleniak, TC1

Other Studies

2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and ganciclovir

ArticleYear
Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.
    Current eye research, 1999, Volume: 19, Issue:6

    Topics: Animals; Antiviral Agents; beta-Galactosidase; Cataract; Cell Count; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Female; Galactosides; Ganciclovir; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Therapy; Herpesvirus 1, Human; Indoles; Lens Capsule, Crystalline; Rabbits; Recombinant Fusion Proteins; Retroviridae; Staining and Labeling; Thymidine Kinase; Transfection

1999
Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
    Cancer gene therapy, 2001, Volume: 8, Issue:8

    Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; beta-Galactosidase; Brain Neoplasms; Combined Modality Therapy; DNA, Recombinant; Drug Resistance, Neoplasm; Fas Ligand Protein; Galactosides; Ganciclovir; Gene Expression; Genetic Therapy; Genetic Vectors; Glioblastoma; Herpesvirus 1, Human; Humans; Indoles; Lomustine; Membrane Glycoproteins; Thymidine Kinase; Tumor Cells, Cultured

2001